GHK-Cu safety changes with the way it’s used.
“Well tolerated” sounds reassuring. The useful part is what follows: who used it, how they used it and how long anyone watched. A cream and an injection leave very different questions to answer.

Tolerated
What happened in that study?
The review of topical research describes a limited human evidence base. Small studies can tell us what happened during the work. They can’t catch every possible reaction or settle what happens with long-term use. A reassuring result still needs those boundaries.
People using topical copper-peptide products report redness, itching and dryness in skincare communities. Those are anecdotes, without reliable rates. They also involve whole formulas, so we can’t turn them into a tidy list of effects caused by one ingredient. There’s no honest percentage to put beside them here.
If a safety claim leaves out the route, ask for it. Experience with skincare doesn’t establish that an injected preparation is safe.
Immune response
The body could react to the preparation.
FDA’s injectable GHK-Cu entry raises concerns about an immune reaction. It points to possible clumping of molecules and impurities related to the peptide. FDA also says human safety information is limited. That’s a stated concern, rather than a report that a particular person had a reaction.
On its page current as of April 22, 2026, FDA puts injectable GHK-Cu among the withdrawn nominations. The requests were withdrawn; the safety concern remains. That isn’t clearance, approval or a move into Category 1. FDA gives no withdrawal date for this entry.
That listing specifically concerns injections. It can’t be stretched to cover every topical product, and it can’t be read as permission to compound an injectable medicine.
Unknown
Some answers are still missing.
GHK-Cu has no FDA-approved drug label. That means there’s no FDA-reviewed list of interactions, pregnancy information or dosing instructions to copy here. Compounded medicines aren’t FDA-approved either. A prescription doesn’t turn a missing answer into a settled one.
A personal conversation can cover your medical history, other medicines and any copper-related condition. Those are things to discuss, not a screening system invented by this guide. Useful questions include what supports the proposed use, what follow-up would involve and who handles a possible reaction.
The dosage page explains why research amounts don’t supply a personal plan. For a symptom or a current care question, the clinician responsible for that care can consider details this page cannot.